{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T04:16:44Z","timestamp":1694492204338},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1252,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>Aims<\/jats:italic>\n          <\/jats:bold>\u2007To evaluate initial blood pressure effects of the angiotensin II antagonist losartan (L) immediately after switching from an ACE inhibitor (captopril, C).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>\u2007Two\u2010phase multicentre randomized study in 177 outpatients with mild to moderate essential hypertension. For 6 weeks all patients received 25\u2003mg C twice daily. Then they were randomized double\u2010blind to switch for another 6 weeks to 50\u2003mg L once daily (<jats:italic>n<\/jats:italic>=110) or to maintain C (<jats:italic>n<\/jats:italic>=55). On the first day of the switch they underwent ambulatory blood pressure measurement (ABPM).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>\u2007Within 12\u2003h of first dose, 31% of patients who switched to L had two consecutive systolic BP readings of 30\u2003mmHg below their individual baseline value compared with 24% of patients who stayed on C. In 3% of patients with L and in 6% of the C patients systolic BP readings less than 100\u2003mmHg were recorded within 12\u2003h of first dose. The differences were not statistically significant. There were no clinical symptoms attributable to initial hypotension. During the 6 weeks double\u2010blind therapy, 9% of L patients experienced at least one adverse event, compared with 16% of patients with C.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>\u2007In this study the angiotensin II antagonist losartan was effective and generally well tolerated when administered immediately after pretreatment with an ACE inhibitor.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1998.00753.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:31:23Z","timestamp":1047357083000},"page":"169-172","source":"Crossref","is-referenced-by-count":5,"title":["Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor"],"prefix":"10.1111","volume":"46","author":[{"given":"Juergen","family":"Scholze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Stapff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_4_2_2","first-page":"205","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists.","volume":"45","author":"Timmermanns PBMWM","year":"1993","journal-title":"Pharmacol Rev"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.66.4.883"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6368.832"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198402040-00008"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)91373-C"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.56"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb05696.x"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.12.243S"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.6.1345"},{"key":"e_1_2_4_11_2","first-page":"765","article-title":"Randomised, double\u2010blind, parallel study of the anti\u2010hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.","volume":"9","author":"Chan JCN","year":"1995","journal-title":"J Human Hypertension"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.1.112"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198708003-00006"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.4.405"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.1991.tb00419.x"},{"key":"e_1_2_4_16_2","first-page":"22","article-title":"Discovery of losartan, the first specific non\u2010peptide angiotensin II receptor antagonist.","volume":"11","author":"Siegl PKS","year":"1993","journal-title":"J Hypertension"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199507001-00005"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00266358"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1998.00753.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1998.00753.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2125.1998.00753.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1998.00753.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:17:42Z","timestamp":1694405862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1998.00753.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2125.1998.00753.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1998.00753.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}